These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37596304)

  • 41. Does the cytokine adsorber CytoSorb
    Scharf C; Weinelt F; Schroeder I; Paal M; Weigand M; Zoller M; Irlbeck M; Kloft C; Briegel J; Liebchen U
    Ann Intensive Care; 2022 May; 12(1):44. PubMed ID: 35599248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults.
    Weidhase L; Wellhöfer D; Schulze G; Kaiser T; Drogies T; Wurst U; Petros S
    BMC Infect Dis; 2019 Feb; 19(1):150. PubMed ID: 30760225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial.
    Jarczak D; Roedl K; Fischer M; de Heer G; Burdelski C; Frings DP; Sensen B; Boenisch O; Tariparast PA; Kluge S; Nierhaus A
    Blood Purif; 2023; 52(2):183-192. PubMed ID: 36075200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with Hyperbilirubinemia.
    Gräfe C; Paal M; Winkels M; Irlbeck M; Liebchen U; Scharf C
    Blood Purif; 2023; 52(11-12):849-856. PubMed ID: 37820591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a Multivalent Transcriptomic Metric for Diagnosing Surgical Sepsis and Estimating Mortality Among Critically Ill Patients.
    Brakenridge SC; Chen UI; Loftus T; Ungaro R; Dirain M; Kerr A; Zhong L; Bacher R; Starostik P; Ghita G; Midic U; Darden D; Fenner B; Wacker J; Efron PA; Liesenfeld O; Sweeney TE; Moldawer LL
    JAMA Netw Open; 2022 Jul; 5(7):e2221520. PubMed ID: 35819783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of CytoSorb®: a systematic review and meta-analysis.
    Becker S; Lang H; Vollmer Barbosa C; Tian Z; Melk A; Schmidt BMW
    Crit Care; 2023 May; 27(1):215. PubMed ID: 37259160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The addition of Cytosorb in patients on VA-ECMO improves urinary output and ICU survival.
    Lovrić D; Pašalić M; Križanac S; Kovačić K; Skorić B; Jurin H; Miličić D; Premužić V
    Ther Apher Dial; 2024 Feb; 28(1):103-111. PubMed ID: 37697687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of sepsis biomarkers and their kinetics in the prognosis of septic shock due to bacterial infections.
    Bahloul M; Bradii S; Turki M; Bouchaala K; Ben Hamida C; Chelly H; Ayedi F; Bouaziz M
    Anaesthesiol Intensive Ther; 2021; 53(4):312-318. PubMed ID: 35257563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
    Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
    Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine hemoadsorption with CytoSorb
    Monard C; Bianchi N; Poli E; Altarelli M; Debonneville A; Oddo M; Liaudet L; Schneider A
    Crit Care; 2023 Jan; 27(1):36. PubMed ID: 36691082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock.
    Phua J; Koay ES; Lee KH
    Shock; 2008 Mar; 29(3):328-33. PubMed ID: 18277855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lactate indices as predictors of in-hospital mortality or 90-day survival after admission to an intensive care unit in unselected critically ill patients.
    Hayashi Y; Endoh H; Kamimura N; Tamakawa T; Nitta M
    PLoS One; 2020; 15(3):e0229135. PubMed ID: 32150560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
    Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
    Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial.
    Haertel F; Lehmann T; Heller T; Fritzenwanger M; Pfeifer R; Kretzschmar D; Otto S; Bogoviku J; Westphal J; Bruening C; Gecks T; Kaluza M; Moebius-Winkler S; Schulze PC
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature.
    Houschyar KS; Pyles MN; Rein S; Nietzschmann I; Duscher D; Maan ZN; Weissenberg K; Philipps HM; Strauss C; Reichelt B; Siemers F
    Int J Artif Organs; 2017 May; 40(5):205-211. PubMed ID: 28525674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative cytokine levels and their predictive value in critical patients after major abdominal surgery: a retrospective cohort study.
    Yan Y; Jin P; Lu J; Cheng D; Xu J; Yuan J; Yu Z; Hu Y
    Ann Palliat Med; 2022 Jan; 11(1):1-15. PubMed ID: 35144393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.
    Zuccari S; Damiani E; Domizi R; Scorcella C; D'Arezzo M; Carsetti A; Pantanetti S; Vannicola S; Casarotta E; Ranghino A; Donati A; Adrario E
    Blood Purif; 2020; 49(1-2):107-113. PubMed ID: 31434083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CORRELATIVE ASSOCIATION OF OXYGENATION AND SEPSIS PANELS WITH THE USE OF ACE2 INHIBITORS AND WITHOUT IT IN THE CONDITIONS OF SEPTIC SHOCK IN COVID-19-INFECTED AND NON-INFECTED PATIENTS (COHORT STUDY).
    Rurua M; Sanikidze T; Machvariani K; Pachkoria E; Ormotsadze G; Intskirveli N; Mikadze I; Didbaridze T; Ratiani L
    Georgian Med News; 2023; (340-341):249-253. PubMed ID: 37805906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Sequential Use of Extracorporeal Cytokine Removal Devices in an Adolescent With COVID-19 Receiving Continuous Renal Replacement Therapy.
    Hui WF; Chan RWY; Wong CK; Kwok KHA; Cheung WL; Chung FS; Leung KKY; Hon KL; Ku SW
    ASAIO J; 2022 Dec; 68(12):e230-e234. PubMed ID: 36318755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.